Dyne Therapeutics Inc
DYN9.400USD
+0.070+0.75%
收盤 07/17, 16:00（美東）報價延遲15分鐘
0.000USD0.000盤後交易 07/17, 20:00 (美東)
1.07B總市值
虧損本益比TTM
單季報
單季報+年報
單季報
年報
YOY
隱藏空白列
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
營業費用
76.95%122.37M
43.46%97.11M
69.67%105.66M
7.83%71.96M
52.11%69.16M
68.61%67.69M
47.29%62.27M
26.50%66.74M
27.05%45.46M
-22.74%40.15M
-1.14%42.28M
74.89%52.76M
42.37%35.78M
81.68%51.96M
216.32%42.77M
--30.16M
--25.13M
--28.60M
--13.52M
研發費用
139.00%106.45M
39.02%81.81M
67.96%92.80M
5.30%62.26M
18.66%44.54M
77.29%58.84M
59.36%55.25M
26.71%59.13M
32.94%37.54M
-21.54%33.19M
-5.04%34.67M
95.48%46.66M
51.60%28.24M
91.42%42.30M
277.21%36.51M
--23.87M
--18.63M
--22.10M
--9.68M
折舊攤銷及損耗
25.50%502.00K
25.00%500.00K
1.62%438.00K
-7.19%400.00K
-2.91%400.00K
-0.25%400.00K
7.75%431.00K
-13.80%431.00K
-3.06%412.00K
0.25%401.00K
33.33%400.00K
100.80%500.00K
41.67%425.00K
84.33%400.00K
71.43%300.00K
--249.00K
--300.00K
--217.00K
--175.00K
營業利潤
-76.95%-122.37M
-43.46%-97.11M
-69.67%-105.66M
-7.83%-71.96M
-52.11%-69.16M
-68.61%-67.69M
-47.29%-62.27M
-26.50%-66.74M
-27.05%-45.46M
22.74%-40.15M
1.14%-42.28M
-74.89%-52.76M
-42.37%-35.78M
-81.68%-51.96M
-216.32%-42.77M
---30.16M
---25.13M
---28.60M
---13.52M
淨非營業利息收入（費用）
利息收入
136.51%7.10M
333.58%7.59M
323.76%9.28M
219.53%7.05M
101.07%3.00M
30.48%1.75M
142.41%2.19M
400.45%2.21M
549.13%1.49M
637.36%1.34M
390.76%903.00K
110.00%441.00K
38.55%230.00K
468.75%182.00K
--184.00K
--210.00K
--166.00K
--32.00K
----
利息費用
----
----
----
----
----
----
----
----
----
----
----
----
----
-100.00%0.00
-100.00%0.00
--0.00
--0.00
--81.00K
--130.00K
其他非經營性收入（費用）
-117.59%-89.00K
96.29%-26.00K
-488.89%-742.00K
48.53%-192.00K
334.26%506.00K
-2820.83%-701.00K
-1300.00%-126.00K
-3830.00%-373.00K
-620.00%-216.00K
-200.00%-24.00K
---9.00K
--10.00K
---30.00K
---8.00K
100.00%0.00
--0.00
----
--0.00
---270.00K
稅前利潤
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
-205.91%-42.58M
---29.95M
---24.97M
---28.65M
---13.92M
除稅後利潤
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
-205.91%-42.58M
---29.95M
---24.97M
---28.65M
---13.92M
持續經營利潤
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
-205.91%-42.58M
---29.95M
---24.97M
---28.65M
---13.92M
歸属于母公司的淨利潤
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
-205.91%-42.58M
---29.95M
---24.97M
---28.65M
---13.92M
歸屬普通股東的淨利潤
-75.72%-115.36M
-34.37%-89.54M
-61.31%-97.13M
-0.31%-65.10M
-48.57%-65.65M
-71.63%-66.64M
-45.49%-60.21M
-24.09%-64.90M
-24.18%-44.19M
25.02%-38.83M
2.81%-41.38M
-74.61%-52.30M
-42.51%-35.58M
-80.76%-51.79M
-205.91%-42.58M
---29.95M
---24.97M
---28.65M
---13.92M
基本每股收益
-29.57%-1.05
19.13%-0.88
2.28%-0.96
35.12%-0.70
-3.26%-0.81
-47.63%-1.09
-23.31%-0.99
-7.17%-1.08
-13.77%-0.78
26.84%-0.73
3.70%-0.80
-73.04%-1.01
-36.64%-0.69
-73.75%-1.00
-159.80%-0.83
---0.58
---0.50
---0.58
---0.32
稀釋每股收益
-29.57%-1.05
19.13%-0.88
2.28%-0.96
35.12%-0.70
-3.26%-0.81
-47.63%-1.09
-23.31%-0.99
-7.17%-1.08
-13.77%-0.78
26.84%-0.73
3.70%-0.80
-73.04%-1.01
-36.64%-0.69
-73.75%-1.00
-159.80%-0.83
---0.58
---0.50
---0.58
---0.32
每股派息
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
貨幣單位
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
審計意見
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
